Veeva Systems Inc (VEEV) 30.12 $VEEV
IBD 50: Growth Stocks Get Jiggy In New Market Uptrend
at Investor's Business Daily - Fri Feb 13, 5:43PM CST
If recent market action tells us anything, it's that three signs of strength by the Nasdaq -- one on Jan. 8, another on Jan. 22 and the other on Feb. 10 -- meant something after all. The market's back in a confirmed uptrend, but it doesn't...
VEEV: 30.12 (+0.17), UA: 73.76 (-0.19), LCI: 57.78 (-0.91), ORLY: 205.55 (-1.02), HDB: 58.41 (-0.98), SPR: 49.35 (+0.47), ULTA: 136.66 (+0.59), IPGP: 87.26 (+0.07)
The Data Behind The Rule Of 40%
Tomasz Tunguz - Seeking Alpha - Thu Feb 12, 10:12AM CST
(click to enlarge) In “The Rule of 40% for a Healthy SaaS Company” Brad Feld shared the rule of thumb growth investors often apply to judge the attractiveness of a business. “The 40% rule is that your growth rate + your...
BV: 8.54 (+0.20), BOX: 20.18 (+0.01), JIVE: 5.34 (+0.02), MDSO: 46.58 (+1.48), MRIN: 7.04 (+0.04), N: 101.72 (+3.38), FLTX: 38.99 (+0.56), ATHN: 134.60 (+4.95), VEEV: 30.12 (+0.17), WIX: 18.84 (-0.26), NOW: 77.55 (+1.60), PFPT: 55.97 (+0.38), LNKD: 269.00 (+1.83), LOGM: 52.22 (+4.17), DWRE: 55.99 (+0.45), WDAY: 91.84 (+0.67), MOBL: 9.53 (-0.21), MKTO: 28.24 (+0.20), TRAK: 42.84 (+2.06), SPLK: 64.18 (+2.25), HUBS: 43.29 (+6.22), CRM: 62.85 (+1.59)
Cerner Fails To Inspire Wall Street Despite Solid Q4
at Investor's Business Daily - Wed Feb 11, 10:34AM CST
Cerner (CERN) stock fell Wednesday, as Wall Street found little inspiration from the medical software maker's Q4 earnings posted after the close Tuesday. Cerner logged earnings of 47 cents a share, up 21% from the year-earlier and in line with...
VEEV: 30.12 (+0.17), CERN: 70.98 (+1.15)
Veeva to Release Fiscal 2015 Fourth Quarter and Full Year Results on March 3, 2015
Business Wire - Thu Feb 05, 5:51PM CST
Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for life sciences, today announced that it will release results for its fiscal fourth quarter and full fiscal year ended January 31, 2015 after the market close on March 3, 2015. Veeva will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss its financial results.
VEEV: 30.12 (+0.17)
UBS Says Veeva Systems Inc. Is a "Buy" -- but Should You Care?
Rich Smith, The Motley Fool - Motley Fool - Thu Feb 05, 3:30PM CST
VEEV Total Return Price data by YCharts What: On Thursday, Feb. 5, Swiss megabanker UBS announced it is upgrading shares of Veeva Systems . According to ratings news aggregator StreetInsider.com , the banker now rates Veeva a "buy" and...
VEEV: 30.12 (+0.17)
InsiderInsights.com Daily Round Up 2/2/15: ALNY, MRTX, ZSAN, RLI
InsiderInsights - at Seeking Alpha - Tue Feb 03, 9:27AM CST
EGLE: 9.98 (-0.02), CKX: 15.30 (+0.34), IP: 57.31 (+0.12), ZSAN: 11.00 (-0.01), FDO: 77.86 (+0.31), SHLD: 35.70 (+2.32), VEEV: 30.12 (+0.17), DVA: 73.10 (-3.29), RLI: 49.57 (+0.47), ALNY: 95.54 (+1.67), FN: 16.94 (+0.02), FFIV: 116.64 (+1.37), MRTX: 22.51 (-0.08), MSFT: 43.87 (+0.78), MA: 87.14 (-0.38)
Veeva's Vault Pursues $2 Billion Life Sciences Market
at Investor's Business Daily - Fri Jan 30, 5:22PM CST
Software developer Veeva Systems (VEEV) sees 85% of its revenue from customer relationship management software deployed in the life sciences industry. The company reports about 250,000 drug sales representatives -- about half the population worldwide...
VEEV: 30.12 (+0.17), EMC: 27.99 (+0.12), CRM: 62.85 (+1.59)
InsiderInsights.com Daily Round Up 1/26/15: THRM, FXCM, OPK, TCBI
InsiderInsights - at Seeking Alpha - Wed Jan 28, 3:00AM CST
AZZ: 44.86 (+0.22), IGTE: 39.53 (+0.62), BALT: 1.74 (+0.09), EGBN: 36.43 (-0.31), FXCM: 2.21 (-0.01), TCBI: 48.51 (+0.81), THRM: 41.21 (+0.38), VEEV: 30.12 (+0.17), VSAR: 18.04 (-0.55), PN: 13.35 (-0.14), LNKD: 269.00 (+1.83), OPK: 13.80 (-0.28), NERV: 4.68 (+0.09), CAS: 6.14 (-0.01), SGNT: 27.75 (-0.41), ARIA: 7.35 (+0.45), TWTR: 48.50 (+0.55), BKE: 49.59 (-0.16)
Stocks Open Down In Soft Trade; MeadWestvaco, Rock-Tenn Surge
at Investor's Business Daily - Mon Jan 26, 9:34AM CST
Stocks started the week with quiet losses Monday, as corporate news fueled some of the opening's more significant moves. The S&P 500 dropped 0.7%, with technology stocks posting four of the index's five largest losses. The Dow Jones industrial...
VEEV: 30.12 (+0.17), RKT: 70.00 (+0.69), MAT: 27.61 (+0.17), MWV: 53.91 (+0.59), TXN: 57.97 (+0.53), MSFT: 43.87 (+0.78), SIMO: 29.08 (-0.39)
Cerner, Athenahealth And Veeva Chase Cloud-Based EHR
at Investor's Business Daily - Fri Jan 23, 3:55PM CST
A new wrinkle in federal rules this year aims to urge more hospitals and other medical providers into the 21st century. Those expectations have helped lift a handful of companies in IBD's Computer Software-Medical group, a group at the intersection...
VEEV: 30.12 (+0.17), IMS: 25.68 (+0.22), WDAY: 91.84 (+0.67), GOOGL: 551.16 (+5.15), ORCL: 43.93 (+0.04), CERN: 70.98 (+1.15), CRM: 62.85 (+1.59), ATHN: 134.60 (+4.95)
The Compression In SaaS Valuations
Tomasz Tunguz - at Seeking Alpha - Fri Jan 23, 1:52PM CST
(click to enlarge) In 2015, SaaS companies trade at a 30% lower multiple of revenue than last year. In early 2014, the typical SaaS company traded at about 9.2x their next-twelve-months of revenue. Since August 2014, that figure has dropped by...
RALY: 12.75 (+0.25), BV: 8.54 (+0.20), HDP: 22.81 (+0.83), BNFT: 21.08 (+0.84), MRIN: 7.04 (+0.04), RP: 19.30 (+0.49), ZEN: 25.38 (+1.02), N: 101.72 (+3.38), FLTX: 38.99 (+0.56), NEWR: 33.75 (-2.10), NOW: 77.55 (+1.60), LNKD: 269.00 (+1.83), LOGM: 52.22 (+4.17), SPSC: 68.39 (+1.39), QLYS: 47.95 (+1.46), TRAK: 42.84 (+2.06), LOCK: 14.10 (-0.19), IL: 11.48 (+0.13), JIVE: 5.34 (+0.02), EOPN: 8.55 (-0.01), FIVN: 3.78 (-0.09), MDSO: 46.58 (+1.48), CSLT: 9.19 (+0.13), CSOD: 35.03 (+2.02), LPSN: 10.74 (+0.38), ATHN: 134.60 (+4.95), WIX: 18.84 (-0.26), VEEV: 30.12 (+0.17), ULTI: 163.76 (+1.60), PFPT: 55.97 (+0.38), DWRE: 55.99 (+0.45), WDAY: 91.84 (+0.67), CVT: 28.33 (+1.52), MKTO: 28.24 (+0.20), MOBL: 9.53 (-0.21), RNG: 16.04 (unch), BSFT: 27.58 (+0.14), SPLK: 64.18 (+2.25), DATA: 99.90 (+1.40), HUBS: 43.29 (+6.22), CTCT: 42.48 (+0.72), CRM: 62.85 (+1.59)
Conatus Pharmaceuticals Implements Veeva Vault eTMF and QualityDocs to Speed Global Clinical Trials of New Biologic Emricasan
Business Wire - Thu Jan 22, 6:00AM CST
To improve visibility, control, and collaboration for its ongoing and planned clinical trials, San Diego-based biotech Conatus Pharmaceuticals selected cloud-based Veeva Vault eTMF and Veeva Vault QualityDocs - applications for the management of clinical study and quality and development documentation, respectively. As the company expanded its network of external partners across a growing number of sites worldwide, Conatus sought a fully paperless solution to reduce costs and provide an efficient way for all parties - including a largely mobile clinical workforce - to access content. With Veeva Vault eTMF and Veeva Vault QualityDocs, Conatus has gained a single, authoritative source for verified, current documents, streamlining information sharing across the enterprise.
VEEV: 30.12 (+0.17), CNAT: 5.92 (+0.10)
InsiderInsights.com Daily Round Up 1/14/15: OPK, REN, VEEV, CO
InsiderInsights - at Seeking Alpha - Thu Jan 15, 10:41AM CST
AFAM: 30.88 (+0.37), BBW: 20.94 (+0.14), BBY: 39.11 (-0.08), GOOG: 549.01 (+6.08), VEEV: 30.12 (+0.17), BBBY: 77.91 (-0.49), OPK: 13.80 (-0.28), REN: 1.14 (unch), AVHI: 15.16 (+0.04), GOOGL: 551.16 (+5.15), SIX: 45.11 (-0.05), BNCL: 11.54 (-0.02), CO: 4.75 (-0.06), GRPN: 7.97 (+0.51), SPN: 21.72 (+0.89), ALCO: 45.40 (+1.44), KPTI: 27.12 (-0.13), CRM: 62.85 (+1.59)
'Mad Money' Lightning Round: Starbucks Is One of the Great Growth Companies of All Time
at The Street - Thu Jan 15, 5:00AM CST
Cramer says to avoid Teekay Shipping, Synergy Resources and STMicroelectronics.
VEEV: 30.12 (+0.17), SBUX: 91.58 (-0.24), CY: 14.76 (+0.01), TK: 46.69 (+1.36), TSO: 81.92 (+0.50), PZZA: 62.11 (-1.11), NAT: 10.20 (+0.10), DPZ: 100.00 (-0.56), NXPI: 84.79 (-0.60), SYRG: 11.87 (-0.12), STM: 8.91 (-0.21), ADBE: 76.51 (+1.92)
Cramer's Lightning Round - Stay Away From Oil (1/14/15)
SA Editor Michael Hopkins - at Seeking Alpha - Wed Jan 14, 11:54PM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, January 14. Bullish calls: Veeva (NYSE: VEEV ) : Cramer called the company "a very good cloud play. There are a lot of bears in it. Big short...
SBUX: 91.58 (-0.24), VEEV: 30.12 (+0.17), TK: 46.69 (+1.36), PZZA: 62.11 (-1.11), DPZ: 100.00 (-0.56), NXPI: 84.79 (-0.60), SYRG: 11.87 (-0.12), STM: 8.91 (-0.21), ADBE: 76.51 (+1.92)
Jim Cramer's 'Mad Money' Recap: Will You Still Hate the Markets Tomorrow?
at The Street - Wed Jan 14, 7:22PM CST
Cramer wonders how the markets that were so loved just a few weeks ago could be so hated this week.
KO: 41.99 (-0.18), CY: 14.76 (+0.01), MNST: 117.74 (-1.77), TK: 46.69 (+1.36), NXPI: 84.79 (-0.60), ADBE: 76.51 (+1.92), VEEV: 30.12 (+0.17), SBUX: 91.58 (-0.24), ESPR: 67.13 (-0.33), TSO: 81.92 (+0.50), PZZA: 62.11 (-1.11), NAT: 10.20 (+0.10), DPZ: 100.00 (-0.56), SYRG: 11.87 (-0.12), CRL: 73.61 (-0.33), STM: 8.91 (-0.21)
Veeva to Participate in Upcoming Investor Conference
Business Wire - Mon Jan 12, 6:21PM CST
Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for life sciences, today announced that Matt Wallach, President and Co-founder, will present at the J.P. Morgan Healthcare Conference on Thursday, January 15, 2015, at 9:30 AM Pacific time in San Francisco, CA.
VEEV: 30.12 (+0.17), JPM: 59.67 (+0.10)
Veeva, Zulily pop on Stifel upgrade, coverage launch
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 10:09AM CST
VEEV: 30.12 (+0.17), ZU: 14.22 (-0.30)
Keryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch
Business Wire - Thu Jan 08, 6:01AM CST
In 2014, Keryx Biopharmaceuticals needed to quickly build a commercial foundation for product sales and marketing to support its first FDA-approved product, Auryxia(TM) (ferric citrate). Keryx required a best-of-breed solution that would enable business agility and continuous improvement, plus easily accommodate change and rapid growth. Keryx found it in Veeva Commercial Cloud - a single solution that brings together customer data, multichannel interactions, and compliant content for a fully orchestrated customer experience. At launch, Keryx was ready with Veeva Commercial Cloud, including Veeva CRM, Veeva CRM Approved Email, and closed loop marketing (CLM); Veeva Vault PromoMats for promotional materials management; and Veeva Network customer master.
VEEV: 30.12 (+0.17), KERX: 11.63 (-0.60)
Veeva Systems and BMI SYSTEM Partner to Deliver Complete EFPIA Compliance Management Solution
PR Newswire Europe - Thu Jan 08, 12:04AM CST
BARCELONA, Spain and PARIS, January 8, 2015 /PRNewswire/ --
VEEV: 30.12 (+0.17)
IBD 50: Growth Stocks Get Jiggy In New Market Uptrend
at Investor's Business Daily - Fri Feb 13, 5:43PM CST
If recent market action tells us anything, it's that three signs of strength by the Nasdaq -- one on Jan. 8, another on Jan. 22 and the other on Feb. 10 -- meant something after all. The market's back in a confirmed uptrend, but it doesn't...
VEEV: 30.12 (+0.17), UA: 73.76 (-0.19), LCI: 57.78 (-0.91), ORLY: 205.55 (-1.02), HDB: 58.41 (-0.98), SPR: 49.35 (+0.47), ULTA: 136.66 (+0.59), IPGP: 87.26 (+0.07)
The Data Behind The Rule Of 40%
Tomasz Tunguz - Seeking Alpha - Thu Feb 12, 10:12AM CST
(click to enlarge) In “The Rule of 40% for a Healthy SaaS Company” Brad Feld shared the rule of thumb growth investors often apply to judge the attractiveness of a business. “The 40% rule is that your growth rate + your...
BV: 8.54 (+0.20), BOX: 20.18 (+0.01), JIVE: 5.34 (+0.02), MDSO: 46.58 (+1.48), MRIN: 7.04 (+0.04), N: 101.72 (+3.38), FLTX: 38.99 (+0.56), ATHN: 134.60 (+4.95), VEEV: 30.12 (+0.17), WIX: 18.84 (-0.26), NOW: 77.55 (+1.60), PFPT: 55.97 (+0.38), LNKD: 269.00 (+1.83), LOGM: 52.22 (+4.17), DWRE: 55.99 (+0.45), WDAY: 91.84 (+0.67), MOBL: 9.53 (-0.21), MKTO: 28.24 (+0.20), TRAK: 42.84 (+2.06), SPLK: 64.18 (+2.25), HUBS: 43.29 (+6.22), CRM: 62.85 (+1.59)
Cerner Fails To Inspire Wall Street Despite Solid Q4
at Investor's Business Daily - Wed Feb 11, 10:34AM CST
Cerner (CERN) stock fell Wednesday, as Wall Street found little inspiration from the medical software maker's Q4 earnings posted after the close Tuesday. Cerner logged earnings of 47 cents a share, up 21% from the year-earlier and in line with...
VEEV: 30.12 (+0.17), CERN: 70.98 (+1.15)
Veeva to Release Fiscal 2015 Fourth Quarter and Full Year Results on March 3, 2015
Business Wire - Thu Feb 05, 5:51PM CST
Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for life sciences, today announced that it will release results for its fiscal fourth quarter and full fiscal year ended January 31, 2015 after the market close on March 3, 2015. Veeva will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss its financial results.
VEEV: 30.12 (+0.17)
UBS Says Veeva Systems Inc. Is a "Buy" -- but Should You Care?
Rich Smith, The Motley Fool - Motley Fool - Thu Feb 05, 3:30PM CST
VEEV Total Return Price data by YCharts What: On Thursday, Feb. 5, Swiss megabanker UBS announced it is upgrading shares of Veeva Systems . According to ratings news aggregator StreetInsider.com , the banker now rates Veeva a "buy" and...
VEEV: 30.12 (+0.17)
InsiderInsights.com Daily Round Up 2/2/15: ALNY, MRTX, ZSAN, RLI
InsiderInsights - at Seeking Alpha - Tue Feb 03, 9:27AM CST
EGLE: 9.98 (-0.02), CKX: 15.30 (+0.34), IP: 57.31 (+0.12), ZSAN: 11.00 (-0.01), FDO: 77.86 (+0.31), SHLD: 35.70 (+2.32), VEEV: 30.12 (+0.17), DVA: 73.10 (-3.29), RLI: 49.57 (+0.47), ALNY: 95.54 (+1.67), FN: 16.94 (+0.02), FFIV: 116.64 (+1.37), MRTX: 22.51 (-0.08), MSFT: 43.87 (+0.78), MA: 87.14 (-0.38)
Veeva's Vault Pursues $2 Billion Life Sciences Market
at Investor's Business Daily - Fri Jan 30, 5:22PM CST
Software developer Veeva Systems (VEEV) sees 85% of its revenue from customer relationship management software deployed in the life sciences industry. The company reports about 250,000 drug sales representatives -- about half the population worldwide...
VEEV: 30.12 (+0.17), EMC: 27.99 (+0.12), CRM: 62.85 (+1.59)
InsiderInsights.com Daily Round Up 1/26/15: THRM, FXCM, OPK, TCBI
InsiderInsights - at Seeking Alpha - Wed Jan 28, 3:00AM CST
AZZ: 44.86 (+0.22), IGTE: 39.53 (+0.62), BALT: 1.74 (+0.09), EGBN: 36.43 (-0.31), FXCM: 2.21 (-0.01), TCBI: 48.51 (+0.81), THRM: 41.21 (+0.38), VEEV: 30.12 (+0.17), VSAR: 18.04 (-0.55), PN: 13.35 (-0.14), LNKD: 269.00 (+1.83), OPK: 13.80 (-0.28), NERV: 4.68 (+0.09), CAS: 6.14 (-0.01), SGNT: 27.75 (-0.41), ARIA: 7.35 (+0.45), TWTR: 48.50 (+0.55), BKE: 49.59 (-0.16)
Stocks Open Down In Soft Trade; MeadWestvaco, Rock-Tenn Surge
at Investor's Business Daily - Mon Jan 26, 9:34AM CST
Stocks started the week with quiet losses Monday, as corporate news fueled some of the opening's more significant moves. The S&P 500 dropped 0.7%, with technology stocks posting four of the index's five largest losses. The Dow Jones industrial...
VEEV: 30.12 (+0.17), RKT: 70.00 (+0.69), MAT: 27.61 (+0.17), MWV: 53.91 (+0.59), TXN: 57.97 (+0.53), MSFT: 43.87 (+0.78), SIMO: 29.08 (-0.39)
Cerner, Athenahealth And Veeva Chase Cloud-Based EHR
at Investor's Business Daily - Fri Jan 23, 3:55PM CST
A new wrinkle in federal rules this year aims to urge more hospitals and other medical providers into the 21st century. Those expectations have helped lift a handful of companies in IBD's Computer Software-Medical group, a group at the intersection...
VEEV: 30.12 (+0.17), IMS: 25.68 (+0.22), WDAY: 91.84 (+0.67), GOOGL: 551.16 (+5.15), ORCL: 43.93 (+0.04), CERN: 70.98 (+1.15), CRM: 62.85 (+1.59), ATHN: 134.60 (+4.95)
The Compression In SaaS Valuations
Tomasz Tunguz - at Seeking Alpha - Fri Jan 23, 1:52PM CST
(click to enlarge) In 2015, SaaS companies trade at a 30% lower multiple of revenue than last year. In early 2014, the typical SaaS company traded at about 9.2x their next-twelve-months of revenue. Since August 2014, that figure has dropped by...
RALY: 12.75 (+0.25), BV: 8.54 (+0.20), HDP: 22.81 (+0.83), BNFT: 21.08 (+0.84), MRIN: 7.04 (+0.04), RP: 19.30 (+0.49), ZEN: 25.38 (+1.02), N: 101.72 (+3.38), FLTX: 38.99 (+0.56), NEWR: 33.75 (-2.10), NOW: 77.55 (+1.60), LNKD: 269.00 (+1.83), LOGM: 52.22 (+4.17), SPSC: 68.39 (+1.39), QLYS: 47.95 (+1.46), TRAK: 42.84 (+2.06), LOCK: 14.10 (-0.19), IL: 11.48 (+0.13), JIVE: 5.34 (+0.02), EOPN: 8.55 (-0.01), FIVN: 3.78 (-0.09), MDSO: 46.58 (+1.48), CSLT: 9.19 (+0.13), CSOD: 35.03 (+2.02), LPSN: 10.74 (+0.38), ATHN: 134.60 (+4.95), WIX: 18.84 (-0.26), VEEV: 30.12 (+0.17), ULTI: 163.76 (+1.60), PFPT: 55.97 (+0.38), DWRE: 55.99 (+0.45), WDAY: 91.84 (+0.67), CVT: 28.33 (+1.52), MKTO: 28.24 (+0.20), MOBL: 9.53 (-0.21), RNG: 16.04 (unch), BSFT: 27.58 (+0.14), SPLK: 64.18 (+2.25), DATA: 99.90 (+1.40), HUBS: 43.29 (+6.22), CTCT: 42.48 (+0.72), CRM: 62.85 (+1.59)
Conatus Pharmaceuticals Implements Veeva Vault eTMF and QualityDocs to Speed Global Clinical Trials of New Biologic Emricasan
Business Wire - Thu Jan 22, 6:00AM CST
To improve visibility, control, and collaboration for its ongoing and planned clinical trials, San Diego-based biotech Conatus Pharmaceuticals selected cloud-based Veeva Vault eTMF and Veeva Vault QualityDocs - applications for the management of clinical study and quality and development documentation, respectively. As the company expanded its network of external partners across a growing number of sites worldwide, Conatus sought a fully paperless solution to reduce costs and provide an efficient way for all parties - including a largely mobile clinical workforce - to access content. With Veeva Vault eTMF and Veeva Vault QualityDocs, Conatus has gained a single, authoritative source for verified, current documents, streamlining information sharing across the enterprise.
VEEV: 30.12 (+0.17), CNAT: 5.92 (+0.10)
InsiderInsights.com Daily Round Up 1/14/15: OPK, REN, VEEV, CO
InsiderInsights - at Seeking Alpha - Thu Jan 15, 10:41AM CST
AFAM: 30.88 (+0.37), BBW: 20.94 (+0.14), BBY: 39.11 (-0.08), GOOG: 549.01 (+6.08), VEEV: 30.12 (+0.17), BBBY: 77.91 (-0.49), OPK: 13.80 (-0.28), REN: 1.14 (unch), AVHI: 15.16 (+0.04), GOOGL: 551.16 (+5.15), SIX: 45.11 (-0.05), BNCL: 11.54 (-0.02), CO: 4.75 (-0.06), GRPN: 7.97 (+0.51), SPN: 21.72 (+0.89), ALCO: 45.40 (+1.44), KPTI: 27.12 (-0.13), CRM: 62.85 (+1.59)
'Mad Money' Lightning Round: Starbucks Is One of the Great Growth Companies of All Time
at The Street - Thu Jan 15, 5:00AM CST
Cramer says to avoid Teekay Shipping, Synergy Resources and STMicroelectronics.
VEEV: 30.12 (+0.17), SBUX: 91.58 (-0.24), CY: 14.76 (+0.01), TK: 46.69 (+1.36), TSO: 81.92 (+0.50), PZZA: 62.11 (-1.11), NAT: 10.20 (+0.10), DPZ: 100.00 (-0.56), NXPI: 84.79 (-0.60), SYRG: 11.87 (-0.12), STM: 8.91 (-0.21), ADBE: 76.51 (+1.92)
Cramer's Lightning Round - Stay Away From Oil (1/14/15)
SA Editor Michael Hopkins - at Seeking Alpha - Wed Jan 14, 11:54PM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, January 14. Bullish calls: Veeva (NYSE: VEEV ) : Cramer called the company "a very good cloud play. There are a lot of bears in it. Big short...
SBUX: 91.58 (-0.24), VEEV: 30.12 (+0.17), TK: 46.69 (+1.36), PZZA: 62.11 (-1.11), DPZ: 100.00 (-0.56), NXPI: 84.79 (-0.60), SYRG: 11.87 (-0.12), STM: 8.91 (-0.21), ADBE: 76.51 (+1.92)
Jim Cramer's 'Mad Money' Recap: Will You Still Hate the Markets Tomorrow?
at The Street - Wed Jan 14, 7:22PM CST
Cramer wonders how the markets that were so loved just a few weeks ago could be so hated this week.
KO: 41.99 (-0.18), CY: 14.76 (+0.01), MNST: 117.74 (-1.77), TK: 46.69 (+1.36), NXPI: 84.79 (-0.60), ADBE: 76.51 (+1.92), VEEV: 30.12 (+0.17), SBUX: 91.58 (-0.24), ESPR: 67.13 (-0.33), TSO: 81.92 (+0.50), PZZA: 62.11 (-1.11), NAT: 10.20 (+0.10), DPZ: 100.00 (-0.56), SYRG: 11.87 (-0.12), CRL: 73.61 (-0.33), STM: 8.91 (-0.21)
Veeva to Participate in Upcoming Investor Conference
Business Wire - Mon Jan 12, 6:21PM CST
Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for life sciences, today announced that Matt Wallach, President and Co-founder, will present at the J.P. Morgan Healthcare Conference on Thursday, January 15, 2015, at 9:30 AM Pacific time in San Francisco, CA.
VEEV: 30.12 (+0.17), JPM: 59.67 (+0.10)
Veeva, Zulily pop on Stifel upgrade, coverage launch
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 10:09AM CST
VEEV: 30.12 (+0.17), ZU: 14.22 (-0.30)
Keryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch
Business Wire - Thu Jan 08, 6:01AM CST
In 2014, Keryx Biopharmaceuticals needed to quickly build a commercial foundation for product sales and marketing to support its first FDA-approved product, Auryxia(TM) (ferric citrate). Keryx required a best-of-breed solution that would enable business agility and continuous improvement, plus easily accommodate change and rapid growth. Keryx found it in Veeva Commercial Cloud - a single solution that brings together customer data, multichannel interactions, and compliant content for a fully orchestrated customer experience. At launch, Keryx was ready with Veeva Commercial Cloud, including Veeva CRM, Veeva CRM Approved Email, and closed loop marketing (CLM); Veeva Vault PromoMats for promotional materials management; and Veeva Network customer master.
VEEV: 30.12 (+0.17), KERX: 11.63 (-0.60)
Veeva Systems and BMI SYSTEM Partner to Deliver Complete EFPIA Compliance Management Solution
PR Newswire Europe - Thu Jan 08, 12:04AM CST
BARCELONA, Spain and PARIS, January 8, 2015 /PRNewswire/ --
VEEV: 30.12 (+0.17)
